சார்லஸ் டங்கன் கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சார்லஸ் டங்கன் கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சார்லஸ் டங்கன் கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் Today - Breaking & Trending Today

Geron (GERN) Q2 2021 Earnings Call Transcript

Geron (GERN) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Aleksandra Rizo , John Scarlett , Stephen Willey , Charles Duncan , Charles Duncan Cantor Fitzgerald , Stephen Willey Stifel Nicolaus , Justin Walshb Riley , Justin Walsh , Cantor Fitzgerald , Data Monitoring Committee , Vice President , Chief Financial Officer , Anil Kapur , Risk Factors , Chief Executive , Chief Medical , Independent Data Monitoring Committee , South America , Corporate Strategy , Chief Commercial , November Investor Day , Investor Day , ஒன்றுபட்டது மாநிலங்களில் , அலெக்ஸாண்ட்ரா ரிஜோ , ஜான் ஸ்கார்லெட் ,

Aptinyx Inc. (APTX) Q2 2021 Earnings Call Transcript

APTX earnings call for the period ending June 30, 2021. ....

United States , Laura Chico , Trudy Li , Charles Duncan , Kathryn King , Charles Duncan Cantor Fitzgerald , Tandy Kidd , Laura Chico Wedbush , Harald Murck , Marc Goodman , Norbert Riedel , Ashish Khanna , Nick Smith , Corporate Development , Cantor Fitzgerald , Aptinyx Inc , Private Securities Litigation Reform Act , Chief Operating , Ritu Baral , ஒன்றுபட்டது மாநிலங்களில் , லாரா சிக்கோ , சார்லஸ் டங்கன் , க்யாத்ரிந் கிங் , சார்லஸ் டங்கன் கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் , ஆண்டி கிட் , மார்க் நல்ல மனிதன் ,

Anavex Life Sciences (AVXL) Q2 2021 Earnings Call Transcript

Christopher Missling
[Audio gap] the quest for disease-confined therapies for neurodegenerative disorders. Separately, the independent Data Monitoring Safety Board, DSMB, also like the ongoing clinical trial program, including the late-stage AVATAR RS-002, EXCELLENCE RS-003, and the US Rett syndrome extension study, RS-EP-001 of Anavex 2-73 has also completed its recent pre-planned review of the respective interim safety data for these three separate clinical studies. Upon review of the interim safety data, the DSMB made the following recommendation for each of the three studies. The DSMB recommendation is to continue the studies without modifications.
This is very good news and indicates we re on the right path with all these studies. As a reminder, our clinical strategy is to clearly differentiate from other biopharma companies and clinical studies in CNS. Anavex is continuing to pioneer the approach of big data, including Anavex in clinical trials to leverage the level ....

Jeffrey Cohen , Sandra Boenisch , Tom Bishop , Charles Duncan , Ram Selvaraju , Charles Duncan Cantor Fitzgerald , Christopher Missling , Jeffrey Cohen Ladenburg Thalmann , Abi Research , Cantor Fitzgerald , Ladenburg Thalmann , Anavex Life Sciences , Tom Bishop Bi Research Analyst , Data Monitoring Safety Board , Financial Officer , ஜெஃப்ரி கோஹன் , டோம் பிஷப் , சார்லஸ் டங்கன் , ரேம் செல்வராஜு , சார்லஸ் டங்கன் கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் , இரு ஆராய்ச்சி , கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் , டோம் பிஷப் இரு ஆராய்ச்சி ஆய்வாளர் , தகவல்கள் கண்காணிப்பு பாதுகாப்பு பலகை , நிதி அதிகாரி ,

Axsome Therapeutics, Inc. (AXSM) Q1 2021 Earnings Call Transcript

Good morning, and welcome to the Axsome Therapeutics Conference Call. [Operator Instructions]
I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer at Axsome Therapeutics. Please go ahead.
Mark Jacobson
Chief Operating Officer
Thank you, operator. Good morning, and thank you all for joining us on today s conference call. Our earnings press release providing a corporate update and details of the company s financial results for the first quarter of 2021 crossed the wire a short time ago and is available on our website at axsome.com.
During today s call, we will be making certain forward-looking statements. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our investigational agents, our clinical and non-clinical plans, our plans to present or report additional data, the anticipated conduct in the source of future clinical trials, regulatory plans, ....

United States , Chris Howerton Jefferies , Herriot Tabuteau , Matt Kaplan , Joe Thome , Charles Duncan , Nick Pizzie , Ram Selvaraju , Joon Lee Truist , Charles Duncan Cantor Fitzgerald , Joseph Thome Cowen , Yatin Suneja Guggenheim , Marc Goodman , Lori Englebert , Joon Lee , Roanna Ruiz , Matt Kaplan Ladenburg Thalmann , Chris Howerton , Cedric Ogorman , Amanda Jones , Yatin Suneja , Mark Jacobson , American Psychiatric Association , Axsome Therapeutics Inc , Ladenburg Thalmann , Vamil Divan Mizuho Securities United States ,

Catalyst Pharmaceuticals Inc (CPRX) Q1 2021 Earnings Call Transcript

Greetings and welcome to the Catalyst Pharmaceuticals First Quarter 2021 Results Conference Call. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Alicia Grande, Vice President, Chief Financial Officer and Treasurer. Thank you. You may begin.
Alicia Grande
Vice President, Chief Financial Officer and Treasurer
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst s first quarter 2021 financial results and corporate highlights. Leading the call today, we have Patrick McEnany, Chairman and Chief Executive Officer. We are joined by Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer, and Jeffrey Del Carmen, Chief Commercial Officer. For the question and for the Q&A session, we also have Dr. Gary Ingenito, Chief Medical and Regulatory Officer. ....

United States , Stevenr Miller , Patrick Mcenany , Charles Duncan , Gary Ingenito , Charles Duncan Cantor Fitzgerald , Alicia Grande , Steven Miller , Brian Elsbernd , Joon Lee , Ali Grande , Catalyst Pharmaceuticals First Quarter , Patrickj Mcenany Co , Jacobus Pharmaceuticals , Exchange Commission , Trademark Office , Eleventh Circuit Court , Product Development , Catalyst Pharmaceuticals Inc , Cantor Fitzgerald , Health Canada , National Comprehensive Cancer Network , Vice President , Chief Financial Officer , Chief Executive , Chief Operating Officer ,